Optimal therapy for resectable rectal cancer.

about

Optimal therapy for resectable rectal cancer.

Item

http://www.wikidata.org/entity/Q38664897

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Optimal therapy for resectable rectal cancer.

@en

type

Item

label

Optimal therapy for resectable rectal cancer.

@en

prefLabel

Optimal therapy for resectable rectal cancer.

@en

P1476

Optimal therapy for resectable rectal cancer.

@en

P2093

Subotheni Thavaneswaran

http://www.w3.org/2001/XMLSchema#string

Timothy J Price

http://www.w3.org/2001/XMLSchema#string

P2860

TP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trial.

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society.

Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial.

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.

Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04

Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.

Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer

Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07.

Effect of preoperative radio(chemo)therapy on long-term functional outcome in rectal cancer patients: a systematic review and meta-analysis.

P304

285-302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2016.1130627

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26652907

http://www.w3.org/2001/XMLSchema#string

Optimal therapy for resectable rectal cancer.

about

Optimal therapy for resectable rectal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698